A Randomized, Double-Blind, Placebo and Positive-Controlled, Crossover Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers.

Trial Profile

A Randomized, Double-Blind, Placebo and Positive-Controlled, Crossover Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2012

At a glance

  • Drugs Moxifloxacin; Plazomicin
  • Indications Bacterial infections; Pyelonephritis; Respiratory tract infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 08 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 27 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top